Medicare spending analysis for Hospice and Palliative Care providers
Hospice and Palliative Care accounts for $385.7M in Medicare payments across 11.8K providers.
The specialty's average markup of 3.2x is below the overall Medicare average of 3.77x.
This specialty has been identified by HHS OIG as having elevated fraud risk based on historical enforcement patterns.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2014 | $19.5M | 236.1K | 555 | — |
| 2015 | $25.4M | 311.3K | 728 | +30.3% |
| 2016 | $29.6M | 389.2K | 905 | +16.9% |
| 2017 | $34.4M | 491.4K | 1.0K | +16.1% |
| 2018 | $38.9M | 591.8K | 1.2K | +13.2% |
| 2019 | $43.2M | 577.9K | 1.3K | +11.0% |
| 2020 | $44.8M | 543.3K | 1.4K | +3.7% |
| 2021 | $49.9M | 582.0K | 1.5K | +11.3% |
| 2022 | $48.6M | 643.0K | 1.5K | -2.5% |
| 2023 | $51.3M | 741.9K | 1.6K | +5.6% |
| # | Provider | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| 1 | Boris Krivitsky | NC | $1.3M | 72.4K | $18.28 |
| 2 | Andrew Latchman | AZ | $672.3K | 44.3K | $15.17 |
| 3 | Wesam Aziz | TX | $665.5K | 8.3K | $79.92 |
| 4 | Samuel Uzabel | FL | $581.8K | 40.0K | $14.53 |
| 5 | Ty Hargroder | LA | $575.2K | 3.5K | $162.54 |
| 6 | Valerie Zamudio | CA | $531.8K | 5.2K | $102.33 |
| 7 | Jason Abney | CA | $531.2K | 3.9K | $135.14 |
| 8 | Paul Diehl | CA | $398.9K | 21.5K | $18.52 |
| 9 | Ian Kowalski | FL | $388.5K | 5.4K | $71.96 |
| 10 | Sarmad Ashfaq | PA | $347.0K | 5.2K | $66.96 |
| 11 | Lily Otolorin | VA | $302.3K | 3.1K | $96.56 |
| 12 | Charles Mills | MA | $260.4K | 3.6K | $72.87 |
| 13 | Anand Sandesara | CA | $206.5K | 2.2K | $94.03 |
| 14 | John Finn | MI | $203.2K | 2.1K | $96.51 |
| 15 | Sunil Aggarwal | WA | $202.5K | 4.1K | $49.57 |
| 16 | Lisa Raptis | CA | $195.3K | 1.8K | $109.03 |
| 17 | Mohan Shah | FL | $179.3K | 1.8K | $101.84 |
| 18 | Carolina De Elia | NY | $170.3K | 1.7K | $103.13 |
| 19 | Akta Rajani | TX | $170.0K | 2.6K | $66.66 |
| 20 | Lokesh Kebbehundi Marigowda | NC | $164.5K | 2.5K | $66.34 |
| 21 | Amanda Sedlacek | SD | $158.4K | 5.8K | $27.48 |
| 22 | Amanda Woodward | NE | $155.8K | 2.3K | $67.63 |
| 23 | Babak Goldman | CA | $155.6K | 1.4K | $112.05 |
| 24 | Samuel Anandan | NY | $145.8K | 1.2K | $118.44 |
| 25 | Ajaykumar Patel | MA | $144.7K | 2.6K | $54.97 |
| Code | Description | Payments | Services | Avg/Service |
|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $10.4M | 107.8K | $96.32 |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | $9.9M | 71.0K | $138.94 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $5.1M | 81.3K | $62.94 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | $3.8M | 31.0K | $122.98 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $3.0M | 35.2K | $84.46 |
| 99497 | Advance care planning, first 30 minutes | $2.8M | 45.7K | $61.28 |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | $2.5M | 23.9K | $103.54 |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | $1.4M | 8.7K | $157.96 |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | $1.2M | 15.0K | $81.66 |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | $670.9K | 17.1K | $39.21 |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | $654.1K | 4.6K | $142.59 |
| J2350 | Injection, ocrelizumab, 1 mg | $611.9K | 13.5K | $45.32 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $533.7K | 9.3K | $57.54 |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | $524.6K | 21.5K | $24.37 |
| 99498 | Advance care planning, each additional 30 minutes | $508.1K | 8.7K | $58.44 |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | $474.2K | 4.9K | $96.02 |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | $469.0K | 3.3K | $143.12 |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | $432.8K | 7.5K | $57.41 |
| J3380 | Injection, vedolizumab, 1 mg | $432.0K | 24.9K | $17.35 |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | $367.3K | 2.9K | $125.36 |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.